Novir has filed a notice of an exempt offering of securities to raise $3,200,000.00 in New Debt Financing.
According to filings with the U.S. Securities and Exchange Commission, Novir is raising up to $3,200,000.00 in new funding. Sources indicate that as part of senior management President and Chief Executive Officer, Alexander Kempe played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Novir
Novir is a cutting-edge biotechnology company revolutionizing the way the world perceives and approaches healthcare. At Novir, we challenge the conventional care model by placing our focus on proactive measures rather than waiting for diagnoses. We firmly believe that care shouldnt start at diagnosis, but rather in the early stages of prevention. Our mission is to empower individuals to take charge of their health through innovative services and technologies that enable a pre-care pathway for anyone, anywhere, anytime.
To learn more about Novir, visit http://novir-usa.com/
Novir Linkedin Page: https://www.linkedin.com/company/novir/
Contact:
Alexander Kempe, President and Chief Executive Officer
414-269-9530
https://www.linkedin.com/in/alexander-kempe-52530a7/
SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.